Dear Colleagues,
We are very excited to invite you to attend the First Headache Summit to be held in Israel, November 13 through 17, 2008.
The field of headache medicine has grown in the past 15 years with many new discoveries leading to better treatments of headache patients and improvement in their quality of life. The research into headaches has grown exponentially and we expect further breakthroughs in the near future.
The goal of this meeting is to bring together headache specialists who are at the forefront of research and treatment of headache patients, with family doctors, internists and other physicians who frequently encounter headache patients. The meeting will feature many prominent headache specialists who will discuss new discoveries in the pathogenesis and treatment of migraine and other headaches. You will have a unique opportunity to interact with these top world headache experts and learn about their research and how to improve care of your patients.
We are very fortunate to have Nobel Prize laureate Elie Wiesel give the keynote address.
The meeting will take place at a seaside hotel in Tel-Aviv. The location and the climate at the time of the meeting will allow you to enjoy the natural beauty and warm waters of a Mediterranean beach. Prior to the meeting you can join your colleagues on a trip to visit many of Israel’s ancient historic sites. We are certain that memories of this trip will last a lifetime. Please make your plane and hotel reservations early, so you are not disappointed.
We hope you will join us at this exciting event.
Scientific Program Committee:
Arieh Kuritzky, Israel
Richard Lipton, USA
Hélène Massiou, France
Alexander Mauskop, USA (Chair)
This activity has been planned and implemented in accordance with the Essential Areas and Elements of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Board of Quality Assurance and Utilization Review Physicians, Inc. (ABQAURP) and New York Headache Center. The American Board of Quality Assurance and Utilization Review Physicians, Inc. designates this educational activity for a maximum of 16 AMA PRA Category 1 Credits(tm). Physicians should only claim credit commensurate with the extent of their participation in the activity.
